Atlas’s antibodies are rigorously evaluated for specificity and performance. An additional level of antibody validation (‘Enhanced Validation’) is being added following the recommendations by the International Working Group for Antibody Validation (IWGAV) published in Nature Methods. Over 4,200 antibodies from Atlas’s catalogue have undergone this enhanced validation. They have proposed five conceptual pillars for antibody validation, which should be used in an application-specific manner. At least one of the pillars should be used for an antibody to be validated in a specific application. Atlas Antibodies base the enhanced validation on Human Protein Atlas' interpretation of these pillars.
To find out more, download the 'Enhanced Validation of Antibodies' brochure and watch the video below.